Current Issue March 2012, Vol. 10, No. 1

Issue Highlights

Original Studies

  • Administration of Cisplatin-Based Chemotherapy for Advanced Urothelial Carcinoma in the Community
    March 2012(Vol. 10 | No. 1 | Pages 1-5)

    Guru Sonpavde, Deidre Watson, Marcia Tourtellott, C. Lance Cowey, Beth Hellerstedt, Thomas E. Hutson, Feng Zhan, Nicholas J. Vogelzang

  • Association of Rash With Outcomes in a Randomized Phase II Trial Evaluating Cetuximab in Combination With Mitoxantrone Plus Prednisone After Docetaxel for Metastatic Castration-resistant Prostate Cancer
    March 2012(Vol. 10 | No. 1 | Pages 6-14)

    Mark T. Fleming, Guru Sonpavde, Michael Kolodziej, Sanjay Awasthi, Thomas E. Hutson, Danko Martincic, Ashutosh Rastogi, Steven R. Rousey, Ralph E. Weinstein, Matthew D. Galsky, William R. Berry, Yunfei Wang, Kristi A. Boehm, Lina Asmar, Mary A. Rauch, Tomasz M. Beer

  • Impact of the CKD-EPI Equation for Estimating Renal Function on Eligibility for Cisplatin-based Chemotherapy in Patients With Urothelial Cancer
    March 2012(Vol. 10 | No. 1 | Pages 15-20)

    Che-Kai Tsao, Erin Moshier, Sonia M. Seng, James Godbold, Steven Grossman, Jonathan Winston, William K. Oh, Matthew D. Galsky

  • The Role of IMiDs Alone or in Combination in Prostate Cancer
    21 May 2012

    Chadi Nabhan, Daniel P. Petrylak

  • Neutrophil Number after Interferon-Alfa Treatment is an Independent Predictive Marker of Overall Survival in Metastatic Renal Cell Carcinoma
    21 May 2012

    Takeshi Azuma, Yukihide Matayoshi, Yasushi Nagase, Masaya Oshi

  • Prolonged Therapy With Cabazitaxel in an Octogenarian With Metastatic Castration-Resistant Prostate Cancer
    11 May 2012

    Sumanta K. Pal, Cy A. Stein

  • A Phase II Trial of Intrapatient Dose-Escalated Sorafenib in Patients With Metastatic Renal Cell Carcinoma
    03 May 2012

    Robert Amato, Jim Zhai, James Willis, Somyata Saxena, Melissa DeFoe

  • Metastatic Extraosseous Ewing's Sarcoma (EES)/Primitive Neuroectodermal Tumor (PNET) of the Kidney: 8-Year Durable Response After Induction and Maintenance Chemotherapy
    16 April 2012

    Stephen L. Richey, Priya Rao, Christopher G. Wood, Shreyaskumar Patel, Nizar M. Tannir

    • View More Articles in Press...

On the Cover

Cover Image

Editor-in-Chief:
Oliver Sartor, MD

New Issue Alert

Free Trial Issue

Companion Journals

Attention Qualified Recipients

If you are a qualified recipient of the US print edition of Clinical Genitourinary Cancer, click here to access the online edition.

Access this journal onSciVerse ScienceDirect
Print or Share This Page

About Clinical Genitourinary Cancer

Clinical Genitourinary Cancer is a peer-reviewed journal that publishes original articles describing various aspects of clinical and translational research in genitourinary cancers. Clinical Genitourinary Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of genitourinary cancers. The main emphasis is on recent scientific developments in all areas related to genitourinary malignancies. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.

Clinical Genitourinary Cancer is indexed by PubMed.

Journal Access

Full-text articles are available from June 2002 to the present. Access to abstracts is complimentary. Access to full text is limited to personal subscribers.

Activate Online Access

Journal Ranking

ISI Impact Factor: 1.638

Publishing Information

Clinical Genitourinary Cancer is published by Elsevier.